Authorization Request Forms/Certification/Letter of Medical Necessity

Forms and Documents

Document Name	Status
Form CA-27 CA-27, Authorization Request form and Certification/Letter of Medical Necessity for Opioid Medications Form and Instruction	Modified
Form CA-26 CA-26, Authorization Request Form and Certification/Letter of Medical Necessity for Compounded Drugs Form	Unchanged
Nonmaterial Change Justification CA-27.docx Justification for No Material/Nonsubstantive Change	2017-05-16
Nonmaterial Change Justification CA-27.docx Justification for No Material/Nonsubstantive Change	2017-01-19
Notice to Reviewer CA-26 and House Letter.docx Justification for No Material/Nonsubstantive Change	2016-10-28
10-05-16 Letter from Reps R Scott and Cummings Regarding Compounded Drugs OMB ICR Reference No 201606-1240-0.pdf Supplementary Document	2016-10-27
OMB_Response to September 16 notice_10052016.pdf Supplementary Document	2016-10-13
2016 09 14 PMG letter to Thomas E Perez Secretary of Labor re Uncontroll....pdf Supplementary Document	2016-10-13
Response to Postal Comment and House Letter.docx Supplementary Document	2016-10-12
OPM Salary Table 2016-RUS.pdf Supplementary Document	2016-06-15
BLS OES Salary Table for Physicians May 2015.docx Supplementary Document	2016-06-15
Privacy Act Systems.doc Supplementary Document	2016-06-15
Supporting Statement 1240-XXXX FOR AUTHORIZATION FORMS FOR LETTER OF AUTHORIZATION-MEDICAL NECESSITY FOR PRESCRIPTIONS October 2016.docx Supporting Statement A	2016-10-12

IC Document Collections

IC ID	Document Title	Status
221978	CA-27, Authorization Request form and Certification/Letter of Medical Necessity for Opioid Medications Form and Instruction	Modified
221977	CA-26, Authorization Request Form and Certification/Letter of Medical Necessity for Compounded Drugs Form	Unchanged

ICR Details

OMB Control No: 1240-0055	ICR Reference No: 201705-1240-001
Status: Historical Active	Previous ICR Reference No: 201612-1240-008
Agency/Subagency: DOL/OWCP	Agency Tracking No:
Title: Authorization Request Forms/Certification/Letter of Medical Necessity
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 06/01/2017
	Date Received in OIRA: 05/30/2017
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	10/31/2019	10/31/2019	10/31/2019
Responses	170,000	0	170,000
Time Burden (Hours)	85,000	0	85,000
Cost Burden (Dollars)	0	0	0

---

Abstract: The forms, Authorization Request Form and Certification/Letter of Medical Necessity for Compounded Drugs (CA-26) and Authorization Request Form and Certification/Letter of Medical Necessity Certification/Letter of Medical Necessity for Opioid Medications (CA-27), require an injured worker’s treating physician to answer a number of questions about the prescribed opioids and/or compounded drugs and certify that they are medically necessary to treat the work-related injury. The responses to the questions on the forms are intended to ensure that treating physicians have considered non-opioid and non-compounded drug alternatives, and are only prescribing the most cost effective and medically necessary drugs. The forms will also permit OWCP to more easily track the volume, type, and characteristics of opioids and compounded drugs authorized by the FECA program. The forms will serve as a means for injured workers to continue receiving opioids and compounded drugs only where medically necessary and simultaneously give OWCP greater oversight in monitoring their appropriate use and gather additional data about their use.

---

Authorizing Statute(s): US Code: 5 USC 8103 Name of Law: Federal Employees' Comensation Act
   US Code: 5 USC 8145 Name of Law: Federal Employees' Comensation Act
   US Code: 5 USC 8124 (a) (2) Name of Law: Federal Employees' Comensation Act
   US Code: 5 USC 8149 Name of Law: Federal Employees' Comensation Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 40721	06/22/2016
30-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 61255	09/06/2016
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 2

IC Title	Form No.	Form Name
CA-26, Authorization Request Form and Certification/Letter of Medical Necessity for Compounded Drugs	CA-26 (Length of Therapy Detail, CA-26 (Method of Administration Detail), CA-26	Authorization Request form and Certification/Letter of Medical Necessity for Compounded Drugs ,   Authorization Request Form and Certification/Letter of Medical Necessity for Compunded Drugs (Methods of Administration Detail ,   Authorization Request Form and Certification/Letter of Medical Necessity for Compunded Drugs (Length of Therapy Detail)
CA-27, Authorization Request form and Certification/Letter of Medical Necessity for Opioid Medications	CA-27 (Web), CA-27	Authoriization/Request Form and Certification/Letter of Medical Necessity for Opioid Medications ,   Authorization Request form and Certification/Letter of Medical Necessity for Opioid Medications

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	170,000	170,000	0	0	0	0
Annual Time Burden (Hours)	85,000	85,000	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $17,818,719

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 05/30/2017

---